Primary Antiphospholipid Syndrome Clinical Trial
Official title:
Ocular Findings in Women With Primary Antiphospholipid Syndrome and Their Association to Bad Obstetric Outcome
Antiphospholipid antibody syndrome (APS) is an autoimmune disease characterized by systemic
thrombosis and bad obstetric history. APS secondary to another medical disorder is the most
common. Visual and ocular changes e.g. vaso-occlusive disease of retinal and choroidal
vessels are found in patients with secondary APS. Patients with primary APS have also been
reported to have ocular changes e.g. retinal vascular occlusion
The aim of our study to detect prevalence of ocular changes in women diagnosed with primary
APS and correlation of these changes with adverse obstetric outcome. If a correlation is
present, ocular findings in women with APS could be used in the future as a predictor for
poor obstetric outcome.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01956188 -
Omega 3 in LES and APS
|
N/A | |
Recruiting |
NCT05904301 -
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
|
||
Not yet recruiting |
NCT03540810 -
Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome
|
Phase 3 |